Galvin Gaustad & Stein LLC Buys 602 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• Galvin Gaustad & Stein LLC increased its holdings in Intuitive Surgical by 144.4% in Q1, now owning shares worth approximately $505,000.
• Intuitive Surgical reported a Q2 EPS of $2.19, surpassing expectations and achieving revenue of $2.44 billion, a 21.4% year-over-year increase.
• Approximately 83.64% of Intuitive Surgical's stock is owned by institutional investors, reflecting strong interest in the company among major financial players.

Galvin Gaustad & Stein LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 144.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,019 shares of the medical equipment provider's stock after buying an additional 602 shares during the period. Galvin Gaustad & Stein LLC's holdings in Intuitive Surgical were worth $505,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of ISRG. Castleark Management LLC raised its stake in Intuitive Surgical by 3.4% during the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after purchasing an additional 2,990 shares during the period. Arlington Trust Co LLC grew its holdings in shares of Intuitive Surgical by 34.5% during the 1st quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock valued at $369,000 after acquiring an additional 191 shares in the last quarter. Aaron Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical by 3.2% during the 1st quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock valued at $1,243,000 after acquiring an additional 78 shares in the last quarter. Longbow Finance SA grew its holdings in shares of Intuitive Surgical by 132.0% during the 1st quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider's stock valued at $9,756,000 after acquiring an additional 11,209 shares in the last quarter. Finally, Ewing Morris & Co. Investment Partners Ltd. purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at $454,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

Shares of ISRG traded down $0.54 during trading hours on Friday, reaching $480.55. 1,560,416 shares of the company traded hands, compared to its average volume of 1,994,670. The stock's fifty day moving average is $525.14 and its 200 day moving average is $533.73. The stock has a market cap of $172.27 billion, a P/E ratio of 67.02, a price-to-earnings-growth ratio of 5.25 and a beta of 1.64. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the prior year, the business earned $1.78 earnings per share. The firm's revenue for the quarter was up 21.4% on a year-over-year basis. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on ISRG shares. Royal Bank Of Canada boosted their price target on shares of Intuitive Surgical from $605.00 to $615.00 and gave the company an "outperform" rating in a report on Wednesday, July 23rd. UBS Group boosted their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a report on Wednesday, July 23rd. Finally, Evercore ISI boosted their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a report on Tuesday, July 8th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $592.05.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares of the company's stock, valued at approximately $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Gary S. Guthart sold 7,893 shares of the company's stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $498.64, for a total transaction of $3,935,765.52. Following the sale, the insider directly owned 13,187 shares in the company, valued at $6,575,565.68. This represents a 37.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,903 shares of company stock valued at $7,932,778 over the last quarter. Corporate insiders own 0.70% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.